American Association for Cancer Research

SHERPA: Unknown

People

  1. Scher
    Scher
  2. Kris
    Kris
  3. Rosen
    Rosen
  4. Jhanwar
    Jhanwar
  5. Reuter
    Reuter
  6. Sirotnak
    Sirotnak
  7. Ballangrud-Popovic
    Ballangrud-Popovic
  8. Ghossein
    Ghossein
  9. Haimovitz-Friedman
    Haimovitz-Friedman
  10. Healey
    Healey

Groups

  1. Department of Medicine (27)
  2. Solid Tumor Oncology Division (25)
  3. GSK Faculty (13)
  4. Genitourinary Oncology Service (12)
  5. Sloan Kettering Institute Faculty (12)
  6. Surgery (10)
  7. Department of Pathology and Laboratory Medicine (8)
  8. Molecular Pharmacology and Chemistry Program Faculty (8)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)
  10. Medical Physics (6)
Search Within
  1. "1999"
Formats
  1. Journal Article (50)
  2. Meeting Abstract (20)
  3. Conference Paper (3)
Groups
  1. Department of Medicine (27)
  2. Solid Tumor Oncology Division (25)
  3. GSK Faculty (13)
  4. Genitourinary Oncology Service (12)
  5. Sloan Kettering Institute Faculty (12)
  6. Surgery (10)

More Groups

People
  1. Howard Scher (8)
  2. Mark Kris (6)
  3. Carlos Cordon-Cardo (5)
  4. Gary Schwartz (4)
  5. George Sgouros (4)
  6. Joseph Bertino (4)

More People

Years
  1. 1999 (73)
Publications
  1. Clinical Cancer Research (45)
  2. Cancer Research (28)

Results (73)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reconstitution of nonirradiated mice with donor marrow cells transduced with a fusion construct encoding the Phe22/Ser31 double mutant of human dihydrofolate reductase (dm DHFR) and Green fluorescence protein (GFP)
    Meeting Abstract

    Zhao, S. C.; Banerjee, D.; Takebe, N.; Bertino, J. R.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • Novel mathematical approaches for understanding gene expression data and its role in anticancer drug development and target selection
    Meeting Abstract

    Sharma, S.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • Cytotoxicity and antitumor efficacy of T138067, a novel microtubule disrupter, against MDR-positive tumor cells
    Meeting Abstract

    Santha, E.; Medina, J. C.; Shan, B.; Baichwal, V.; Ladd, A.; Frankmoelle, W. P.; Poruchynsky, M. S.; Chou, T. C.; Jean, J. C.; Timmermans, P. B. M. W. M.; more...
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin (PDX), a new antifolate
    Meeting Abstract

    Krug, L. M.; Ng, K. K.; Miller, V. A.; Heelan, R. T.; Tong, W.; Kelly, J.; Sirotnak, F. M.; Kris, M. G.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • The multitargeted antifolate: Shifting enzymatic targets during development of antifolate resistance
    Meeting Abstract

    Schultz, R. M.; Chen, V. J.; Bertino, J. R.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • 13-cis-retinoic acid (13CRA) causes growth suppression, cyclin d1 repression, but not RAR beta induction, in normal oral epithelial cells in an in vitro model of oral carcinogenesis
    Meeting Abstract

    Suh, G. D.; Boyle, J. O.; Lin, D.; Sacks, P. G.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • The Hsp90 chaperone system as a potential therapeutic target: Identification of a geldanamycin dimer that induces the selective degradation of HER-family tyrosine kinases
    Meeting Abstract

    Zheng, F. Z. F.; Münster, P. N.; Kuduk, S.; Danishefsky, S.; Sepp-Lorenzino, L.; Rosen, N.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • The use of the prostate xenograft CWR22 and its androgen independent sublines in the preclinical development of herceptin
    Meeting Abstract

    Higgins, B.; Fox, W. D.; Maiese, K.; Fazzari, M.; Scher, H. I.; Agus, D. B.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by co-administration of ZD1839 (Iressa™), an inhibitor of EGF receptor tyrosine kinase
    Meeting Abstract

    Sirotnak, F. M.; Miller, V. A.; Scher, H. I.; Kris, M. G.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • Phase I study of oral ZD1839 (Iressa™), a novel inhibitor of epidermal growth factor receptor tyrosine kinase (EGFR-TK): Evidence of good tolerability and activity
    Meeting Abstract

    Kris, M.; Ranson, M.; Ferry, D.; Hammond, L.; Averbuch, S.; Ochs, J.; Rowinsky, E.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save

    • American Association for Cancer Research – authorized name for: